Accordingly, this study showed that silencing of AURKA in p53-knockdown cancer cells sensitized the A549 cancer cells to gefitinib, which also proved the inhibitory action of p53 in decreasing the ability of AURKA in conferring resistance to gefitinib. The gene discussed is AURKA; the disease is cancer.